Literature DB >> 20683683

Molecular- and flow cytometry-based diagnosis of primary immunodeficiency disorders.

Joao B Oliveira1, Thomas A Fleisher.   

Abstract

Primary immunodeficiencies are an expanding group of genetic disorders resulting in recurrent and/or severe infections, autoimmunity, or autoinflammation. The laboratory plays a critical role in the diagnosis of these conditions given their frequently overlapping signs and symptoms. We discuss here advances in flow cytometry and molecular techniques applied to the study of primary immunodeficiencies.

Entities:  

Mesh:

Year:  2010        PMID: 20683683     DOI: 10.1007/s11882-010-0137-8

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  48 in total

Review 1.  Flow cytometry: an introduction.

Authors:  Alice L Givan
Journal:  Methods Mol Biol       Date:  2004

Review 2.  Pathogenic or not? And if so, then how? Studying the effects of missense mutations using bioinformatics methods.

Authors:  Janita Thusberg; Mauno Vihinen
Journal:  Hum Mutat       Date:  2009-05       Impact factor: 4.878

Review 3.  Sequencing technologies - the next generation.

Authors:  Michael L Metzker
Journal:  Nat Rev Genet       Date:  2009-12-08       Impact factor: 53.242

4.  Bruton's tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females.

Authors:  T Futatani; C Watanabe; Y Baba; S Tsukada; H D Ochs
Journal:  Br J Haematol       Date:  2001-07       Impact factor: 6.998

Review 5.  Molecular and cellular pathogenesis of X-linked lymphoproliferative disease.

Authors:  Kim E Nichols; Cindy S Ma; Jennifer L Cannons; Pamela L Schwartzberg; Stuart G Tangye
Journal:  Immunol Rev       Date:  2005-02       Impact factor: 12.988

6.  Flow cytometric determination of intracytoplasmic Wiskott-Aldrich syndrome protein in peripheral blood lymphocyte subpopulations.

Authors:  S Kawai; M Minegishi; Y Ohashi; Y Sasahara; S Kumaki; T Konno; H Miki; J Derry; S Nonoyama; T Miyawaki; K Horibe; N Tachibana; E Kudoh; Y Yoshimura; Y Izumikawa; M Sako; S Tsuchiya
Journal:  J Immunol Methods       Date:  2002-02-01       Impact factor: 2.303

7.  Primary immunodeficiencies: 2009 update.

Authors:  Luigi D Notarangelo; Alain Fischer; Raif S Geha; Jean-Laurent Casanova; Helen Chapel; Mary Ellen Conley; Charlotte Cunningham-Rundles; Amos Etzioni; Lennart Hammartröm; Shigeaki Nonoyama; Hans D Ochs; Jennifer Puck; Chaim Roifman; Reinhard Seger; Josiah Wedgwood
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

8.  Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.

Authors:  Raif S Geha; Luigi D Notarangelo; Jean-Laurent Casanova; Helen Chapel; Mary Ellen Conley; Alain Fischer; Lennart Hammarström; Shigeaki Nonoyama; Hans D Ochs; Jennifer M Puck; Chaim Roifman; Reinhard Seger; Josiah Wedgwood
Journal:  J Allergy Clin Immunol       Date:  2007-10       Impact factor: 10.793

Review 9.  Phagocyte immunodeficiencies and their infections.

Authors:  Sergio D Rosenzweig; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2004-04       Impact factor: 10.793

Review 10.  Defects in the leukocyte adhesion cascade.

Authors:  Amos Etzioni
Journal:  Clin Rev Allergy Immunol       Date:  2010-02       Impact factor: 8.667

View more
  3 in total

Review 1.  Laboratory diagnosis of primary immunodeficiencies.

Authors:  Bradley A Locke; Trivikram Dasu; James W Verbsky
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 8.667

Review 2.  Application of Flow Cytometry in the Evaluation of Primary Immunodeficiencies.

Authors:  Thomas A Fleisher; Manisha Madkaikar; Sergio D Rosenzweig
Journal:  Indian J Pediatr       Date:  2016-02-11       Impact factor: 1.967

3.  Primary immunodeficiency.

Authors:  Christine McCusker; Richard Warrington
Journal:  Allergy Asthma Clin Immunol       Date:  2011-11-10       Impact factor: 3.406

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.